Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-PM-PBB3 Tau PET in Cognitive Impairment
NCT04169126Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Apr 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of florzolotau in Alzheimer's disease (AD), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
florzolotau
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04169126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169126.